New inhaled drug shows promise for lung scarring and heart strain
NCT ID NCT06635850
First seen Feb 21, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This study tests an inhaled medicine called mosliciguat for people with high blood pressure in the lungs caused by scarring lung disease. About 135 adults will receive either the drug or a placebo for 16 weeks. The goal is to see if the drug improves blood flow in the lungs and walking ability.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Arizona Pulmonary Specialists
Phoenix, Arizona, 85012, United States
-
Brown Medicine
East Providence, Rhode Island, 02915, United States
-
Duke University Health System - Duke Clinic
Durham, North Carolina, 27710, United States
-
Florida Lung, Asthma & Sleep Specialists/Clinical Research Specialists, LLC
Celebration, Florida, 34746, United States
-
Harbor-UCLA Medical Center - Torrance
Torrance, California, 90502, United States
-
Houston Methodist Lung Center
Houston, Texas, 77030, United States
-
Hoxworth Blood Center
Cincinnati, Ohio, 45267, United States
-
Lewis Katz School of Medicine
Philadelphia, Pennsylvania, 19140, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Northwestern University
Chicago, Illinois, 60026, United States
-
Norton Pulmonary Specialists
Louisville, Kentucky, 40202, United States
-
PulmonIx
Greensboro, North Carolina, 27403, United States
-
Ronald Reagan UCLA Medical Center
Los Angeles, California, 90024, United States
-
Summit Health
Bend, Oregon, 97701, United States
-
University of California Davis School of Medicine
Sacramento, California, 95817, United States
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Utah Health
Salt Lake City, Utah, 84132-0001, United States
Conditions
Explore the condition pages connected to this study.